Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors

Ítems similars

• Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors
  per: Hurwitz, Selwyn J., et al.
  Publicat: (2013)
• Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine
  per: Bertoletti, Nicole, et al.
  Publicat: (2019)
• Combination Nucleoside/ Nucleotide Reverse Transcriptase Inhibitors
  per: Akanbi, Maxwell O, et al.
  Publicat: (2012)
• Ligand similarity guided receptor selection enhances docking accuracy and recall for non-nucleoside HIV reverse transcriptase inhibitors
  per: Stanton, Richard A., et al.
  Publicat: (2015)
• Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2
  per: Miller, Siennah R., et al.
  Publicat: (2020)